Yes, ketorolac (Toradol) can be safely co-administered with buprenorphine/naloxone (Suboxone)
Ketorolac is safe to use with Suboxone because ketorolac is a non-opioid NSAID that does not interact with buprenorphine's opioid receptor binding, and there are no contraindications or drug-drug interactions between these medications. The FDA label for Suboxone lists only hypersensitivity to buprenorphine or naloxone as contraindications, with no mention of NSAIDs like ketorolac 1.
Key Clinical Points
Mechanism and Safety:
- Ketorolac works through COX inhibition (non-opioid mechanism) and does not compete with or affect buprenorphine's partial μ-opioid receptor agonist activity
- The FDA pharmacology data for Suboxone demonstrates no clinically significant interactions with non-opioid analgesics 1
- Ketorolac has been shown to have minimal psychomotor effects and is suitable for outpatient use, unlike opioid analgesics 2
Clinical Context for Pain Management: When patients on Suboxone require acute pain management, the 2006 Annals of Internal Medicine guidelines address the complexity of using opioid analgesics with buprenorphine due to buprenorphine's high μ-receptor affinity 3. However, these concerns are specific to opioid-opioid interactions and do not apply to NSAIDs like ketorolac.
Important Caveats
One case report exists of respiratory depression when epidural buprenorphine (150 mcg) was combined with intramuscular ketorolac 30 mg 4. However, this involved:
- Epidural (not sublingual) buprenorphine administration
- Post-thoracotomy setting with multiple confounding factors
- A route of administration not relevant to Suboxone (sublingual) therapy
This isolated case does not represent a contraindication for combining oral/sublingual Suboxone with intramuscular or oral ketorolac in typical clinical scenarios.
Standard NSAID precautions apply:
- Monitor for GI bleeding risk
- Assess renal function
- Limit duration to ≤5 days for ketorolac
- Consider gastroprotection in high-risk patients
The combination is appropriate and often preferred because it provides analgesia without the complications of adding full opioid agonists to buprenorphine therapy, which would require higher opioid doses due to receptor competition or potentially necessitate discontinuing Suboxone 3.